These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Treatment of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review and meta-analysis. Erdogan M; Esatoglu SN; Kilickiran Avci B; Hatemi G Intern Emerg Med; 2024 Apr; 19(3):731-743. PubMed ID: 38378970 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of novel-targeted drugs in the treatment of pulmonary arterial hypertension: a Bayesian network meta-analysis. Fu W; He W; Li Y; Chen Y; Liang J; Lei H; Fu L; Chen Y; Ren N; Jiang Q; Shen Y; Ma R; Wang T; Wang X; Zhang N; Xiao D; Liu C Drug Deliv; 2021 Dec; 28(1):1007-1019. PubMed ID: 34060401 [No Abstract] [Full Text] [Related]
14. [The achievements of the modern specific therapy of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: focus on the stimulator of soluble guanylate cyclase riociguat]. Gratsianskaya SE; Valieva ZS; Martynyuk TV Ter Arkh; 2020 Oct; 92(9):77-84. PubMed ID: 33346435 [TBL] [Abstract][Full Text] [Related]
15. Treatment of pulmonary arterial hypertension in connective tissue disease. Grünig E Drugs; 2012 May; 72(8):1039-56. PubMed ID: 22621693 [TBL] [Abstract][Full Text] [Related]
16. Clinical utility of treprostinil in the treatment of pulmonary arterial hypertension: an evidence-based review. Buckley MS; Berry AJ; Kazem NH; Patel SA; Librodo PA Core Evid; 2014; 9():71-80. PubMed ID: 25018685 [TBL] [Abstract][Full Text] [Related]
18. Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis. Kuwana M; Blair C; Takahashi T; Langley J; Coghlan JG Ann Rheum Dis; 2020 May; 79(5):626-634. PubMed ID: 32161055 [TBL] [Abstract][Full Text] [Related]
19. [Efficacy and safety of endothelin receptor antagonists combined with phosphodiesterase 5 inhibitor in the treatment of pulmonary arterial hypertension: a network meta-analysis]. Fu WH; Chen PL; Xia JL; Fu L; Shen Y; He WJ; Chen YH; Ren N; Jiang Q; Ma R; Wang T; Wang XN; Zhang NF; Liu CL Zhonghua Jie He He Hu Xi Za Zhi; 2022 Feb; 45(2):158-170. PubMed ID: 35135085 [No Abstract] [Full Text] [Related]